Bombardier to supply 47 additional Francilien trains to Île-de-France Mobilités in Greater Paris
- A fleet of 360 Francilien trains: the largest Île-de-France train series
- In 2022, these 360 Francilien trains will operate on the SNCF Transilien network serving Gare du Nord (lines H and K), Gare St Lazare (lines J and L), and Gare de l’Est (line P)
BERLIN, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Mobility solution provider Bombardier Transportation has received an order for 47 Francilien train sets (334 cars) from the French national railway corporation, Société nationale des chemins de fer français (SNCF) on behalf of the Greater Paris public transport authority, Île-de-France Mobilités. The order, a call off from a contract signed in 2006 with SNCF for a maximum of 372 trains, is valued at approximately 330 million euro ($378 million US). These trains, entirely financed by Île-de-France Mobilités, 42 seven-car train sets and five eight-car train sets, will be rolled out on lines L, J and P on the SNCF Transilien network to continue modernizing the fleet. With this order, the 360 Francilien train fleet will be the largest rail series in Île-de-France.
“This train is the pride of the Bombardier Transportation France employees and the Crespin site in the Hauts-de France Region, workplace of around 2000 people. This “Made in France” train illustrates the work excellence of engineers who designed the train in 2006, of operators who produce it since 2009, and of our expert technicians who ensure the train operation every day alongside SNCF. The Francilien, which is tailor-made for the dense Île-de-France urban transportation ecosystem, has a remarkable performance track record and is greatly appreciated by passengers,” said Laurent Bouyer, president of Bombardier Transportation France.
With over 240 trains operating today, the Francilien symbolizes modern transportation in Île-de-France and induces passengers to take public transportation. The Francilien has become a new reference for daily trips, fit for a capital city like Paris, offering high seated capacity, onboard comfort, a unique colorful interior design. Wide doors and large vestibules with level access meet the demands of the dense Île-de-France network and improve the dwell time. Also, performance and respect for the environment are key to its design. Equipped with state-of-the-art technology, the Francilien contributes to improve the punctuality of the lines thanks to the highest level of reliability and availability. For example, Line H, which has a Francilien fleet, reached the highest punctuality score in Île-de-France for the first semester 2018 according to the punctuality bulletin published by Île-de-France Mobilités in September 2018.
To support the renewal of the Île-de-France rolling stock and to contribute to the Mirina scheme, Bombardier will increase the Francilien production pace in Crespin from September 2019.
Renowned as France's first industrial rail site, about 2,000 people work on Bombardier's facility in Crespin (Nord), including 500 engineers and managers. The company designs, builds and commissions different types of equipment and is specialized in double deck platforms. Three emblematic projects are now in production: 1) OMNEO (in the Premium and Regio 2N regional versions) is an extra-capacity, double-deck train for the Regions of France, which ordered 401 train sets in a contract signed in 2010. 2) Francilien is an ultra-modern commuter train for Greater Paris. Île-de-France Mobilités has ordered 360 trains. Operating since December 2009, it is the best performing train of the SNCF Transilien network, servicing the P, L, J, K and H lines 3) RER NG, under a contract signed in 2017 as part of a consortium for Île-de-France Mobilités, will operate on the E and D lines of the RER.
About Bombardier Transportation
Bombardier Transportation is a global mobility solution provider leading the way with the rail industry’s broadest portfolio. It covers the full spectrum of solutions, ranging from trains to sub-systems and signalling to complete turnkey transport systems, e-mobility technology and data-driven maintenance services. Combining technology and performance with empathy, Bombardier Transportation continuously breaks new ground in sustainable mobility by providing integrated solutions that create substantial benefits for operators, passengers and the environment. Headquartered in Berlin, Germany, Bombardier Transportation employs around 39,850 people and its products and services operate in over 60 countries.
With over 69,500 employees across four business segments, Bombardier is a global leader in the transportation industry, creating innovative and game-changing planes and trains. Our products and services provide world-class transportation experiences that set new standards in passenger comfort, energy efficiency, reliability and safety.
Headquartered in Montreal, Canada, Bombardier has production and engineering sites in 28 countries across the segments of Transportation, Business Aircraft, Commercial Aircraft and Aerostructures and Engineering Services. Bombardier shares are traded on the Toronto Stock Exchange (BBD). In the fiscal year ended December 31, 2017, Bombardier posted revenues of $16.2 billion US. News and information are available at bombardier.com or follow us on Twitter @Bombardier.
Notes to editors
For news, related material and photos, visit our newsroom at www.rail.bombardier.com/en/newsroom.html. Please subscribe to our RSS Feed to receive press releases or follow Bombardier Transportation on Twitter @BombardierRail.
Bombardier and OMNEO are trademark of Bombardier Inc. or its subsidiaries.
Media Relations, France
+33 6 07 78 95 38
Global media relations
+49 30 98607 1687
You can also contact one of our worldwide contacts for specific press inquiries.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Tenaris to Acquire IPSCO Tubulars from TMK22.3.2019 13:58:00 CET | Pressemelding
LUXEMBOURG, March 22, 2019 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE, Buenos Aires and Mexico: TS and MTA Italy: TEN) announced today that it has entered into a definitive agreement to acquire from PAO TMK, a Russian company and manufacturer of steel pipe, 100% of the shares of its wholly owned U.S. subsidiary IPSCO Tubulars, Inc., for US$1,209 million, on a cash-free, debt-free basis, which includes US$270 million of working capital. The transaction is subject to regulatory approvals, including approval by the U.S. antitrust authorities, and other customary conditions. IPSCO Tubulars is a U.S. domestic producer of seamless and welded OCTG and line pipe products, with an annual production capacity of 450,000 metric tons of steel bars, 400,000 metric tons of seamless pipe and 1,000,000 metric tons of welded pipe, and production facilities spread throughout the country. The acquisition would enhance Tenaris’s position and local manufacturing presence in the U.S. market, extending its produc
Oxford Immunotec Announces Chief Financial Officer Transition21.3.2019 21:01:00 CET | Pressemelding
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that Richard Altieri, the Company’s Chief Financial Officer (CFO), will retire on April 30, 2019. The Company has appointed Matthew McLaughlin, currently Chief Financial Officer, GE Healthcare – U.S. and Canada, as his successor. Mr. McLaughlin will join Oxford Immunotec as CFO on April 8, 2019. Today’s announcement concludes an extensive search process conducted by the Company. As part of the planned succession, Mr. Altieri, who has led Oxford Immunotec’s global finance organization as CFO since 2012, will remain an active member of the Company’s management team until his retirement date. “During his seven year tenure, Rick successfully managed multiple financing rounds, including the Company's IPO, the acquisition and financial integration of three companies and, most recently, the dives
Test Release - 3-21-2019 - 119240921.3.2019 20:29:00 CET | Pressemelding
Test Sub Headline - 1951992 Chicago, March 21, 2019 (GLOBE NEWSWIRE) -- Test Release™. Attachment sample
Blackhawks, Flyers, Sabres and Lightning Headline the 2019 NHL Global Series21.3.2019 15:34:00 CET | Pressemelding
Chicago Blackhawks and Philadelphia Flyers to Open Regular Season in Prague, Czech Republic on Oct. 4 Buffalo Sabres and Tampa Bay Lightning to Face Off in a Pair of Games in Stockholm, Sweden on Nov. 8 and Nov. 9 2019 NHL Global Series Challenge to feature Blackhawks vs. Eisbären Berlin on Sept. 29 in Berlin, Germany and Flyers vs. Lausanne HC on Sept. 30 in Lausanne, Switzerland Tickets to Games in Berlin, Prague and Stockholm Available for Purchase on Wednesday, March 27; Tickets to Game in Lausanne Available for Purchase on Wednesday, April 10 NEW YORK/TORONTO, March 21, 2019 (GLOBE NEWSWIRE) -- The National Hockey League (NHL) and the National Hockey League Players’ Association (NHLPA), in conjunction with Live Nation Sweden, today announced that the Buffalo Sabres, Chicago Blackhawks, Philadelphia Flyers and Tampa Bay Lightning will participate in the 2019 NHL Global Series. The Chicago Blackhawks and Philadelphia Flyers will play their 2019-20 season-opening game against each ot
Farmako: World's Largest Import Contract for Pharmaceutical Cannabis21.3.2019 15:10:00 CET | Pressemelding
German Farmako secures 50 tonnes of flowers and oils from Polish company Pharmacann Polska FRANKFURT, March 21, 2019 (GLOBE NEWSWIRE) -- Farmako will import 50 tonnes of pharmaceutical cannabis from Pharmacann Polska into the European market over the next four years. This provides the basis for a reliable supply of pharmaceutical cannabis for millions of patients in the European healthcare system. The company expects a total revenue of several hundred million Euros from the agreed exclusive partnership. Founded in September 2018, Farmako now has grown to 40 employees and is distributing high-quality pharmaceutical cannabis to German pharmacies since March 2019. This is the biggest Cannabis contract to date, and the first big contract without participation of a Canadian LP. Farmako has signed an exclusive and binding agreement to import and distribute 50 tons of pharmaceutical cannabis over four years. Farmako and Pharmacann Polska enter strategic partnership to develop custom tailored
NexOptic Appoints Rich Geruson, Former Lexmark CEO, to Board of Directors21.3.2019 14:00:00 CET | Pressemelding
VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- NexOptic Technology Corp. ("NexOptic" or the "Company") (TSX VENTURE: NXO) (OTCQX: NXOPF) (FRANKFURT: E3O1) is pleased to announce that Richard J. (Rich) Geruson has joined its Board of Directors, effective immediately. Mr. Geruson’s experience spans CEO roles at Lexmark International, Phoenix Technologies and VoiceSignal Technologies, and Senior Vice President and executive positions at Nokia, IBM, Toshiba, and McKinsey & Co. As CEO of Lexmark International, a multibillion-dollar imaging technology and solutions company with 10,000 employees, he grew printer sales faster than at any time in the preceding 10 years while simultaneously executing extensive process reengineering, transforming the business from negative EBITDA and high debt to positive multi-hundred-million-dollar EBITDA and a healthy debt profile. While CEO of Phoenix Technologies, he achieved consistently high profit year-over-year for six years straight in